Jack Volker Greiner, D.O., O.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dry Eye Syndromes | 17 | 2023 | 387 | 2.300 |
Why?
|
| Tears | 20 | 2023 | 251 | 1.970 |
Why?
|
| Meibomian Glands | 12 | 2016 | 73 | 1.880 |
Why?
|
| Adenosine Triphosphate | 20 | 2024 | 1989 | 1.800 |
Why?
|
| Conjunctiva | 25 | 2024 | 479 | 1.680 |
Why?
|
| Cornea | 25 | 2024 | 1333 | 1.610 |
Why?
|
| Phospholipids | 15 | 2024 | 786 | 1.610 |
Why?
|
| Glycerylphosphorylcholine | 5 | 2020 | 25 | 1.450 |
Why?
|
| Hyperthermia, Induced | 7 | 2016 | 417 | 1.370 |
Why?
|
| Lens, Crystalline | 21 | 2019 | 389 | 1.330 |
Why?
|
| Eyelid Diseases | 7 | 2016 | 157 | 1.260 |
Why?
|
| Conjunctivitis, Allergic | 8 | 2007 | 125 | 1.230 |
Why?
|
| Archaea | 1 | 2024 | 59 | 0.940 |
Why?
|
| Phosphates | 19 | 2022 | 770 | 0.850 |
Why?
|
| Magnetic Resonance Spectroscopy | 45 | 2024 | 3769 | 0.740 |
Why?
|
| Sjogren's Syndrome | 1 | 2023 | 237 | 0.730 |
Why?
|
| Eyelids | 11 | 2011 | 278 | 0.720 |
Why?
|
| Rabbits | 30 | 2024 | 4772 | 0.700 |
Why?
|
| Ketotifen | 3 | 2003 | 24 | 0.660 |
Why?
|
| Endothelium, Corneal | 6 | 2020 | 215 | 0.640 |
Why?
|
| Phosphorus | 14 | 2020 | 336 | 0.630 |
Why?
|
| Anti-Allergic Agents | 3 | 2005 | 153 | 0.620 |
Why?
|
| Lipid Metabolism | 10 | 2024 | 1902 | 0.620 |
Why?
|
| Cryopreservation | 3 | 2020 | 728 | 0.610 |
Why?
|
| Dibenzoxepins | 4 | 2007 | 28 | 0.610 |
Why?
|
| Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1 | 2017 | 1 | 0.590 |
Why?
|
| Photorefractive Keratectomy | 1 | 2017 | 38 | 0.570 |
Why?
|
| Lasers, Excimer | 1 | 2017 | 69 | 0.550 |
Why?
|
| Corneal Transplantation | 5 | 2020 | 321 | 0.550 |
Why?
|
| Fluorescein | 9 | 2023 | 175 | 0.550 |
Why?
|
| Retina | 9 | 2022 | 2659 | 0.540 |
Why?
|
| Epithelium, Corneal | 2 | 2017 | 253 | 0.510 |
Why?
|
| Hydrocortisone | 1 | 2022 | 1819 | 0.470 |
Why?
|
| Histamine H1 Antagonists | 2 | 2004 | 100 | 0.450 |
Why?
|
| Ophthalmic Solutions | 10 | 2007 | 313 | 0.420 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2161 | 0.420 |
Why?
|
| Contact Lenses | 16 | 1999 | 138 | 0.400 |
Why?
|
| Organophosphorus Compounds | 8 | 1991 | 206 | 0.380 |
Why?
|
| Conjunctivitis | 12 | 1985 | 155 | 0.290 |
Why?
|
| Pandemics | 5 | 2021 | 8654 | 0.290 |
Why?
|
| Patient Discharge | 1 | 2021 | 3443 | 0.290 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 250 | 0.290 |
Why?
|
| Membrane Lipids | 5 | 1995 | 252 | 0.290 |
Why?
|
| Osmolar Concentration | 3 | 2023 | 659 | 0.280 |
Why?
|
| Bandages | 3 | 2008 | 269 | 0.270 |
Why?
|
| Nedocromil | 2 | 2003 | 45 | 0.270 |
Why?
|
| Pheniramine | 1 | 2005 | 1 | 0.260 |
Why?
|
| Naphazoline | 1 | 2005 | 7 | 0.260 |
Why?
|
| Eye | 3 | 2002 | 712 | 0.250 |
Why?
|
| Phosphorus Isotopes | 10 | 1998 | 124 | 0.250 |
Why?
|
| Energy Metabolism | 8 | 2022 | 2882 | 0.240 |
Why?
|
| Prokaryotic Cells | 1 | 2024 | 51 | 0.240 |
Why?
|
| Eye Banks | 4 | 1997 | 40 | 0.240 |
Why?
|
| Contact Lenses, Hydrophilic | 10 | 2002 | 54 | 0.240 |
Why?
|
| Epithelium | 17 | 2011 | 1603 | 0.230 |
Why?
|
| Eukaryota | 1 | 2024 | 102 | 0.230 |
Why?
|
| Eukaryotic Cells | 1 | 2024 | 195 | 0.220 |
Why?
|
| Animals | 56 | 2024 | 168459 | 0.210 |
Why?
|
| Phosphatidylglycerols | 1 | 2022 | 34 | 0.210 |
Why?
|
| Conjunctival Diseases | 6 | 2005 | 110 | 0.210 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 104 | 0.210 |
Why?
|
| Cell Count | 7 | 2020 | 1835 | 0.200 |
Why?
|
| Adaptation, Ocular | 1 | 2022 | 89 | 0.200 |
Why?
|
| Blepharitis | 2 | 1999 | 35 | 0.200 |
Why?
|
| Cromolyn Sodium | 1 | 2002 | 78 | 0.200 |
Why?
|
| Plant Oils | 1 | 2022 | 198 | 0.190 |
Why?
|
| Phosphatidylinositols | 1 | 2022 | 282 | 0.190 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 316 | 0.190 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 188 | 0.190 |
Why?
|
| Dark Adaptation | 1 | 2022 | 222 | 0.190 |
Why?
|
| Blinking | 2 | 2007 | 133 | 0.180 |
Why?
|
| Administration, Cutaneous | 1 | 2022 | 713 | 0.180 |
Why?
|
| Cataract | 5 | 2019 | 832 | 0.170 |
Why?
|
| Nursing Staff | 1 | 2021 | 113 | 0.170 |
Why?
|
| Contrast Media | 4 | 2005 | 5311 | 0.170 |
Why?
|
| Sulfacetamide | 1 | 1999 | 3 | 0.170 |
Why?
|
| Massage | 2 | 1997 | 86 | 0.170 |
Why?
|
| Organ Preservation Solutions | 1 | 2020 | 100 | 0.170 |
Why?
|
| Safety | 2 | 2020 | 1150 | 0.160 |
Why?
|
| Surface-Active Agents | 1 | 1999 | 150 | 0.160 |
Why?
|
| Culture Media | 2 | 2020 | 897 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 398 | 0.150 |
Why?
|
| Humans | 91 | 2024 | 761504 | 0.150 |
Why?
|
| Prednisolone | 1 | 1999 | 326 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 695 | 0.150 |
Why?
|
| Ferrets | 5 | 1991 | 177 | 0.150 |
Why?
|
| Diabetic Foot | 1 | 2022 | 380 | 0.150 |
Why?
|
| Phototherapy | 1 | 2020 | 368 | 0.140 |
Why?
|
| Adenosine Diphosphate | 10 | 1993 | 422 | 0.140 |
Why?
|
| Uvea | 2 | 1995 | 30 | 0.140 |
Why?
|
| Phylogeny | 1 | 2024 | 2811 | 0.140 |
Why?
|
| Dermis | 1 | 1998 | 202 | 0.140 |
Why?
|
| Lens Cortex, Crystalline | 2 | 1994 | 21 | 0.140 |
Why?
|
| Lens Nucleus, Crystalline | 2 | 1994 | 32 | 0.140 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1999 | 247 | 0.140 |
Why?
|
| Double-Blind Method | 9 | 2022 | 12341 | 0.140 |
Why?
|
| Lens Capsule, Crystalline | 2 | 1994 | 39 | 0.130 |
Why?
|
| Education, Distance | 1 | 2020 | 261 | 0.130 |
Why?
|
| Piperidines | 1 | 2004 | 1656 | 0.130 |
Why?
|
| Photoreceptor Cells | 5 | 1984 | 236 | 0.130 |
Why?
|
| Epidermis | 1 | 1998 | 528 | 0.120 |
Why?
|
| Lipids | 4 | 2003 | 3341 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2461 | 0.120 |
Why?
|
| Microscopy, Electron | 12 | 1991 | 2561 | 0.120 |
Why?
|
| Visual Acuity | 4 | 2016 | 2672 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2002 | 2226 | 0.110 |
Why?
|
| Mucus | 5 | 1985 | 341 | 0.110 |
Why?
|
| Emollients | 2 | 2022 | 42 | 0.110 |
Why?
|
| Orbit | 1 | 1997 | 457 | 0.110 |
Why?
|
| Adult | 50 | 2023 | 221177 | 0.110 |
Why?
|
| Bacteria | 1 | 2024 | 2199 | 0.110 |
Why?
|
| Allergens | 4 | 2007 | 1432 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 1997 | 2496 | 0.110 |
Why?
|
| Pruritus | 3 | 2007 | 380 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1880 | 0.110 |
Why?
|
| Models, Animal | 1 | 2020 | 2112 | 0.110 |
Why?
|
| Sugar Phosphates | 6 | 1991 | 44 | 0.110 |
Why?
|
| Carnivora | 2 | 1984 | 28 | 0.110 |
Why?
|
| Cats | 10 | 1994 | 975 | 0.110 |
Why?
|
| Choroid | 2 | 1995 | 360 | 0.100 |
Why?
|
| Tissue Preservation | 3 | 1994 | 174 | 0.100 |
Why?
|
| Middle Aged | 42 | 2023 | 220895 | 0.100 |
Why?
|
| Fluorophotometry | 3 | 2019 | 40 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
| Rats | 9 | 2022 | 23742 | 0.100 |
Why?
|
| Male | 29 | 2024 | 360804 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 8 | 1997 | 945 | 0.090 |
Why?
|
| Aged | 23 | 2023 | 169289 | 0.090 |
Why?
|
| Administration, Topical | 2 | 2005 | 704 | 0.090 |
Why?
|
| Aqueous Humor | 1 | 1991 | 153 | 0.090 |
Why?
|
| Prospective Studies | 9 | 2023 | 54425 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1390 | 0.080 |
Why?
|
| Health Personnel | 2 | 2020 | 3335 | 0.080 |
Why?
|
| Body Temperature | 2 | 2012 | 781 | 0.080 |
Why?
|
| Lissamine Green Dyes | 2 | 2023 | 3 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 6 | 1991 | 209 | 0.080 |
Why?
|
| Body Water | 1 | 1990 | 340 | 0.080 |
Why?
|
| Vitreous Body | 1 | 1991 | 399 | 0.080 |
Why?
|
| Keratoconus | 2 | 1989 | 112 | 0.080 |
Why?
|
| Corneal Diseases | 4 | 2004 | 542 | 0.080 |
Why?
|
| Microvilli | 4 | 1982 | 234 | 0.080 |
Why?
|
| Swine | 9 | 1995 | 5915 | 0.070 |
Why?
|
| Public Health | 1 | 2021 | 2669 | 0.070 |
Why?
|
| Dibenzazepines | 1 | 2007 | 26 | 0.070 |
Why?
|
| Verapamil | 1 | 1988 | 242 | 0.070 |
Why?
|
| Eye Foreign Bodies | 1 | 1988 | 52 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2005 | 2048 | 0.070 |
Why?
|
| Refraction, Ocular | 1 | 2007 | 184 | 0.070 |
Why?
|
| Female | 23 | 2023 | 392644 | 0.060 |
Why?
|
| Ophthalmology | 1 | 2012 | 550 | 0.060 |
Why?
|
| Vision, Low | 1 | 2007 | 163 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 64680 | 0.060 |
Why?
|
| Dogs | 4 | 1995 | 3839 | 0.060 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2004 | 251 | 0.060 |
Why?
|
| Emulsions | 2 | 2022 | 152 | 0.060 |
Why?
|
| Recurrence | 1 | 2017 | 8465 | 0.060 |
Why?
|
| Ouabain | 1 | 1985 | 247 | 0.060 |
Why?
|
| Tissue Survival | 1 | 1984 | 119 | 0.060 |
Why?
|
| Guinea Pigs | 3 | 1995 | 1310 | 0.060 |
Why?
|
| Cricetinae | 3 | 1991 | 2423 | 0.060 |
Why?
|
| Hyperemia | 3 | 2003 | 221 | 0.060 |
Why?
|
| Cell Membrane | 5 | 1994 | 3688 | 0.060 |
Why?
|
| Equipment Design | 1 | 2012 | 3510 | 0.060 |
Why?
|
| Photography | 2 | 1998 | 532 | 0.060 |
Why?
|
| Tissue Banks | 1 | 1984 | 184 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7390 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15842 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2012 | 39106 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5840 | 0.050 |
Why?
|
| Cattle | 3 | 1995 | 3849 | 0.050 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2004 | 84 | 0.050 |
Why?
|
| Centrioles | 1 | 1983 | 80 | 0.050 |
Why?
|
| Absorption | 1 | 2002 | 242 | 0.050 |
Why?
|
| Paper | 1 | 2002 | 84 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 1985 | 574 | 0.050 |
Why?
|
| Anions | 1 | 2002 | 136 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 1981 | 46 | 0.050 |
Why?
|
| Filtration | 1 | 2002 | 228 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 1982 | 170 | 0.050 |
Why?
|
| Mucins | 1 | 1985 | 568 | 0.050 |
Why?
|
| Imidazoles | 1 | 2007 | 1180 | 0.050 |
Why?
|
| Galactose | 1 | 1982 | 297 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7879 | 0.050 |
Why?
|
| Respiratory Protective Devices | 1 | 2021 | 47 | 0.050 |
Why?
|
| Optic Nerve | 2 | 1995 | 572 | 0.050 |
Why?
|
| Interferometry | 3 | 2009 | 100 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 10766 | 0.040 |
Why?
|
| Random Allocation | 2 | 2002 | 2395 | 0.040 |
Why?
|
| Spectrum Analysis | 2 | 1981 | 453 | 0.040 |
Why?
|
| Species Specificity | 3 | 1995 | 2414 | 0.040 |
Why?
|
| Sclera | 2 | 1991 | 190 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 14605 | 0.040 |
Why?
|
| Magnesium | 1 | 1983 | 804 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2547 | 0.040 |
Why?
|
| Antigens | 2 | 2003 | 1443 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1572 | 0.040 |
Why?
|
| Arvicolinae | 2 | 1991 | 21 | 0.040 |
Why?
|
| Cautery | 1 | 1998 | 71 | 0.040 |
Why?
|
| Photomicrography | 1 | 1997 | 71 | 0.040 |
Why?
|
| Reference Values | 2 | 2002 | 4920 | 0.040 |
Why?
|
| Cilia | 1 | 1981 | 495 | 0.040 |
Why?
|
| Mammals | 1 | 1983 | 1132 | 0.040 |
Why?
|
| Adolescent | 12 | 2012 | 88319 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2004 | 3087 | 0.040 |
Why?
|
| Basement Membrane | 2 | 2004 | 349 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 2477 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1995 | 2265 | 0.030 |
Why?
|
| Organoids | 1 | 1983 | 740 | 0.030 |
Why?
|
| Adenine Nucleotides | 2 | 1989 | 111 | 0.030 |
Why?
|
| Eosinophils | 5 | 1985 | 950 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 1997 | 143 | 0.030 |
Why?
|
| Ultrasonics | 1 | 1977 | 208 | 0.030 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1996 | 67 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 632 | 0.030 |
Why?
|
| Salmon | 1 | 1995 | 34 | 0.030 |
Why?
|
| Cyprinidae | 1 | 1995 | 37 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2004 | 3673 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2008 | 3028 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2019 | 561 | 0.030 |
Why?
|
| Humidity | 1 | 1996 | 205 | 0.030 |
Why?
|
| Mast Cells | 6 | 1985 | 1392 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1982 | 1948 | 0.030 |
Why?
|
| Rats, Inbred Strains | 3 | 1985 | 2088 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 148 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4853 | 0.030 |
Why?
|
| Ciliary Body | 1 | 1995 | 167 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4580 | 0.030 |
Why?
|
| NADP | 2 | 1985 | 227 | 0.030 |
Why?
|
| Uridine Diphosphate Galactose | 2 | 1984 | 21 | 0.030 |
Why?
|
| Iris | 1 | 1995 | 232 | 0.030 |
Why?
|
| Infection Control | 1 | 2021 | 981 | 0.030 |
Why?
|
| Basophils | 4 | 1979 | 407 | 0.030 |
Why?
|
| Rose Bengal | 2 | 2005 | 115 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 36426 | 0.030 |
Why?
|
| Sheep | 1 | 1995 | 1440 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 908 | 0.030 |
Why?
|
| Gestational Age | 3 | 1991 | 3577 | 0.020 |
Why?
|
| Cryosurgery | 1 | 1977 | 474 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10445 | 0.020 |
Why?
|
| Time Factors | 8 | 2003 | 39967 | 0.020 |
Why?
|
| Microtubules | 3 | 1982 | 1074 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1996 | 1880 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 2231 | 0.020 |
Why?
|
| Aging | 4 | 1995 | 8708 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1994 | 701 | 0.020 |
Why?
|
| Corneal Edema | 1 | 1991 | 47 | 0.020 |
Why?
|
| Lacrimal Apparatus | 2 | 1984 | 223 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 2005 | 1085 | 0.020 |
Why?
|
| Placebos | 2 | 2007 | 1667 | 0.020 |
Why?
|
| NAD | 2 | 1984 | 614 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 811 | 0.020 |
Why?
|
| Light | 2 | 2009 | 1353 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1985 | 1596 | 0.020 |
Why?
|
| Nucleoside Diphosphate Sugars | 1 | 1988 | 8 | 0.020 |
Why?
|
| Dextrans | 2 | 1994 | 574 | 0.020 |
Why?
|
| Lymphocytes | 3 | 1985 | 2612 | 0.020 |
Why?
|
| Plasma Cells | 4 | 1985 | 599 | 0.020 |
Why?
|
| Papio | 1 | 1989 | 669 | 0.020 |
Why?
|
| Mucous Membrane | 2 | 1981 | 659 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9469 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 2 | 1990 | 129 | 0.020 |
Why?
|
| Corneal Topography | 1 | 2007 | 68 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14666 | 0.020 |
Why?
|
| Color | 1 | 2007 | 299 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2012 | 1294 | 0.020 |
Why?
|
| Lubrication | 1 | 2005 | 21 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2078 | 0.020 |
Why?
|
| Wettability | 1 | 2005 | 27 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2005 | 1903 | 0.020 |
Why?
|
| Sialomucins | 1 | 1985 | 18 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1993 | 8320 | 0.020 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 1984 | 10 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1971 | 0.020 |
Why?
|
| Uridine Diphosphate Glucose | 1 | 1984 | 22 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13639 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 23445 | 0.010 |
Why?
|
| Cadaver | 1 | 1989 | 1358 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 1984 | 189 | 0.010 |
Why?
|
| Corneal Stroma | 1 | 1985 | 171 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1985 | 698 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1980 | 2678 | 0.010 |
Why?
|
| Muridae | 1 | 1983 | 56 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2020 | 4686 | 0.010 |
Why?
|
| Papain | 1 | 1983 | 65 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1989 | 2329 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2008 | 686 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1983 | 252 | 0.010 |
Why?
|
| Glycerophosphates | 1 | 1982 | 47 | 0.010 |
Why?
|
| Retinal Pigments | 1 | 1982 | 83 | 0.010 |
Why?
|
| Endothelium | 1 | 1985 | 765 | 0.010 |
Why?
|
| Child | 6 | 2003 | 80153 | 0.010 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2002 | 38 | 0.010 |
Why?
|
| Oils | 1 | 2002 | 56 | 0.010 |
Why?
|
| Reagent Strips | 1 | 2001 | 39 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5336 | 0.010 |
Why?
|
| Patient Satisfaction | 2 | 2007 | 3461 | 0.010 |
Why?
|
| Synapses | 2 | 1982 | 1769 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1982 | 261 | 0.010 |
Why?
|
| Debridement | 1 | 2004 | 494 | 0.010 |
Why?
|
| Myopia | 1 | 2004 | 253 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1981 | 531 | 0.010 |
Why?
|
| Half-Life | 1 | 1982 | 651 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1984 | 978 | 0.010 |
Why?
|
| Ions | 1 | 2002 | 256 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1982 | 915 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1982 | 263 | 0.010 |
Why?
|
| Papilloma | 1 | 1981 | 140 | 0.010 |
Why?
|
| Conjunctival Neoplasms | 1 | 1981 | 77 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1982 | 231 | 0.010 |
Why?
|
| Prevalence | 2 | 2010 | 15732 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 277 | 0.010 |
Why?
|
| Eyelid Neoplasms | 1 | 1981 | 89 | 0.010 |
Why?
|
| Choline | 1 | 1982 | 515 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1982 | 532 | 0.010 |
Why?
|
| Macrophages | 2 | 1985 | 5769 | 0.010 |
Why?
|
| Insulin | 1 | 1994 | 6596 | 0.010 |
Why?
|
| Corneal Ulcer | 1 | 1979 | 128 | 0.010 |
Why?
|
| Blister | 1 | 1978 | 86 | 0.010 |
Why?
|
| Birefringence | 1 | 1998 | 54 | 0.010 |
Why?
|
| Syndrome | 3 | 1980 | 3267 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1980 | 853 | 0.010 |
Why?
|
| Freezing | 1 | 1977 | 311 | 0.010 |
Why?
|
| Eye Protective Devices | 1 | 1996 | 33 | 0.010 |
Why?
|
| Mitosis | 1 | 1981 | 1187 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1988 | 794 | 0.010 |
Why?
|
| Cell Survival | 1 | 1985 | 5791 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1981 | 852 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1998 | 562 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2004 | 1671 | 0.010 |
Why?
|
| Complex Mixtures | 1 | 1994 | 29 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1994 | 174 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 1981 | 11528 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 20098 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1994 | 135 | 0.010 |
Why?
|
| Gentamicins | 1 | 1994 | 243 | 0.010 |
Why?
|
| Mice | 2 | 1995 | 81525 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1982 | 6216 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1982 | 2909 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 1161 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 1977 | 467 | 0.010 |
Why?
|
| Neutrophils | 1 | 1985 | 3767 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18965 | 0.010 |
Why?
|
| Calcium | 1 | 1985 | 5722 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72334 | 0.010 |
Why?
|
| Aphakia, Postcataract | 1 | 1991 | 52 | 0.010 |
Why?
|
| Keratoplasty, Penetrating | 1 | 1991 | 144 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22176 | 0.010 |
Why?
|
| Sphingomyelins | 1 | 1990 | 105 | 0.010 |
Why?
|
| Glucose | 1 | 1981 | 4346 | 0.010 |
Why?
|
| Lenses, Intraocular | 1 | 1991 | 139 | 0.010 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 1991 | 103 | 0.010 |
Why?
|
| Child, Preschool | 4 | 1995 | 42230 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 405 | 0.000 |
Why?
|
| Biopsy | 1 | 1979 | 6766 | 0.000 |
Why?
|
| Prognosis | 1 | 2007 | 29625 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1985 | 18252 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1982 | 22169 | 0.000 |
Why?
|
| Edema | 1 | 1987 | 766 | 0.000 |
Why?
|
| Neurons | 1 | 1981 | 9463 | 0.000 |
Why?
|
| Methylmethacrylates | 1 | 1980 | 67 | 0.000 |
Why?
|
| Fluoresceins | 1 | 1980 | 235 | 0.000 |
Why?
|
| Histological Techniques | 1 | 1980 | 193 | 0.000 |
Why?
|
| Leukocytes | 2 | 1978 | 2026 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1979 | 212 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1991 | 4445 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1984 | 2645 | 0.000 |
Why?
|
| Refractive Errors | 1 | 1978 | 147 | 0.000 |
Why?
|
| Risk Factors | 1 | 2004 | 74206 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1980 | 2469 | 0.000 |
Why?
|
| Strabismus | 1 | 1978 | 317 | 0.000 |
Why?
|
| Infant | 1 | 1995 | 36192 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 58976 | 0.000 |
Why?
|